Zyrtec and Zyrtec-D 12 Hour to be Readily obtainable in Stores
Nationwide January 2008
FT. WASHINGTON, Pa., November 16, 2007 /PRNewswire/ -- McNeil
Consumer Healthcare, a dividing of McNEIL-PPC, Inc., announced
today that it received agreement from the U.S. Foodstuffs and Remedy
Provision (FDA) for the allergy treatment Zyrtec (cetirizine HCl) to be utilized without a medicament for adults and
children. Zyrtec relieves symptoms due to uninterrupted and seasonal
allergic rhinitis, commonly referred to as indoor and alfresco later
respiratory allergies. Zyrtec also relieves itching due to
hives.
The Zyrtec imprimatur comes one week after the FDA granted the
train approval to retail Zyrtec-D 12 Hour (cetirizine HCl 5
mg/pseudoephedrine HCl 120 mg), which combines Zyrtec with a
decongestant. Zyrtec-D and Zyrtec, the billion one prescribed
allergy medication in the U.S.*, will be elbow in stores
nationwide** in tardily January 2008 without a instruction in its
eccentric-medication force.
"For a decade, Zyrtec, as a formula medication, has been
alleviating people's symptoms from lasting and seasonal
allergies," said Ashley McEvoy, President, McNeil Consumer
Healthcare. "By providing Zyrtec over-the-bar, we're
contribution allergy sufferers greater access to a handy,
compelling and affordable treatment selection that helps alleviate
their unique to allergy symptoms. In factors, for many allergy
sufferers, Zyrtec will outlay up to one third less than
formula Zyrtec."
Zyrtec is a once-a-day medication for adults and children
that relieves indoor and open-air allergy symptoms of sneezing,
runny nose, and weeping eyes for 24 hours. Zyrtec-D 12 Hour
provides the added aid of relieving nasal congestion. The FDA
approved Zyrtec in 5mg and 10mg tablets, 5mg and 10mg chewable
tablets, and 1mg/mL syrup. Zyrtec-D 12 Hour is also approved
as an extended publicity release memorial. Zyrtec also relieves itching due
to hives.
...
Read more...